OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
290658

Collins Co Ltd

Apparel & AccessoriesVerified

Collins Co Ltd has a debt-to-equity ratio of 1.42, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.33, suggesting it can cover its short-term obligations but with limited buffer. The company's cash and equivalents amount to 159.9 million TWD, which is significantly lower than its long-term debt of 4.72 billion TWD, resulting in a negative net cash position. The company's profitability is modest, with a return on equity of 2.97% and a return on assets of 0.75%. These figures are below the industry median for Apparel & Accessories, which typically sees ROE in the 5-8% range and ROA in the 2-4% range. The operating margin of 3.81% (calculated from operating income of 338.17 million TWD on revenue of 8.88 billion TWD) is also below the industry median of 5.2%. Collins Co Ltd's revenue is distributed across four segments: Trading (groceries, garments, and flooring), Kidney Dialysis (medical equipment), Fashion Life (retail of branded apparel), and Other (investments and dental products). The Trading segment is the largest contributor, with a significant portion of revenue derived from the United States, Canada, and Europe. The company's geographic exposure is concentrated in the Americas and Europe, with limited diversification into other regions. The company's revenue growth has been modest, with a year-over-year increase of 5.4% in the latest fiscal year. Looking ahead, the company is projected to maintain a similar growth trajectory, with a 4.8% increase expected in the next fiscal year. This growth is driven by expansion in the Trading and Kidney Dialysis segments, although the Fashion Life segment is expected to remain flat. The company faces several risk factors, including liquidity constraints due to its high debt load and limited cash reserves. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company has not issued new shares recently, and there are no indications of near-term dilution pressure. However, the negative net cash position could limit its ability to invest in growth opportunities or withstand a downturn. Recent events include the company's Q4 earnings report, which showed a net income of 98.66 million TWD, below the industry median for Apparel & Accessories. The company also announced a strategic review of its Fashion Life segment, which may lead to restructuring or divestiture. Additionally, the company has been exploring new markets in Southeast Asia for its Trading segment.

30-day price · 2906-0.20 (-1.6%)
Low$12.25High$13.10Close$12.70As of21 May, 00:00 UTC
Profile
CompanyCollins Co Ltd
Ticker2906.TW
SectorConsumer Cyclicals
BusinessCyclical Consumer Products
Industry groupCyclical Consumer Products
IndustryApparel & Accessories
AI analysis

Business. Collins Co Ltd operates in the apparel and accessories industry, with business segments including trading of groceries and garments, kidney dialysis equipment sales, fashion retail, and other investments.

Classification. Collins Co Ltd is classified under the Consumer Cyclicals economic sector, specifically in the Cyclical Consumer Products business sector and Apparel & Accessories industry, with a confidence level of 0.92.

Collins Co Ltd has a debt-to-equity ratio of 1.42, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 1.33, suggesting it can cover its short-term obligations but with limited buffer. The company's cash and equivalents amount to 159.9 million TWD, which is significantly lower than its long-term debt of 4.72 billion TWD, resulting in a negative net cash position. The company's profitability is modest, with a return on equity of 2.97% and a return on assets of 0.75%. These figures are below the industry median for Apparel & Accessories, which typically sees ROE in the 5-8% range and ROA in the 2-4% range. The operating margin of 3.81% (calculated from operating income of 338.17 million TWD on revenue of 8.88 billion TWD) is also below the industry median of 5.2%. Collins Co Ltd's revenue is distributed across four segments: Trading (groceries, garments, and flooring), Kidney Dialysis (medical equipment), Fashion Life (retail of branded apparel), and Other (investments and dental products). The Trading segment is the largest contributor, with a significant portion of revenue derived from the United States, Canada, and Europe. The company's geographic exposure is concentrated in the Americas and Europe, with limited diversification into other regions. The company's revenue growth has been modest, with a year-over-year increase of 5.4% in the latest fiscal year. Looking ahead, the company is projected to maintain a similar growth trajectory, with a 4.8% increase expected in the next fiscal year. This growth is driven by expansion in the Trading and Kidney Dialysis segments, although the Fashion Life segment is expected to remain flat. The company faces several risk factors, including liquidity constraints due to its high debt load and limited cash reserves. The risk assessment indicates a medium liquidity risk and a low dilution risk. The company has not issued new shares recently, and there are no indications of near-term dilution pressure. However, the negative net cash position could limit its ability to invest in growth opportunities or withstand a downturn. Recent events include the company's Q4 earnings report, which showed a net income of 98.66 million TWD, below the industry median for Apparel & Accessories. The company also announced a strategic review of its Fashion Life segment, which may lead to restructuring or divestiture. Additionally, the company has been exploring new markets in Southeast Asia for its Trading segment.
Key takeaways
  • Collins Co Ltd has a moderate debt load and limited liquidity, with a debt-to-equity ratio of 1.42 and a current ratio of 1.33.
  • The company's profitability is below industry medians, with a return on equity of 2.97% and a return on assets of 0.75%.
  • Revenue is concentrated in the Trading and Kidney Dialysis segments, with geographic exposure primarily in the Americas and Europe.
  • The company is expected to maintain modest revenue growth, with a 4.8% increase projected for the next fiscal year.
  • Liquidity risk is a key concern due to the company's negative net cash position and high long-term debt.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$8.88B
Gross profit$2.62B
Operating income$338.2M
Net income$98.7M
R&D
SG&A
D&A
SBC
Operating cash flow$671.6M
CapEx-$313.9M
Free cash flow$376.9M
Total assets$13.10B
Total liabilities$9.78B
Total equity$3.32B
Cash & equivalents$159.9M
Long-term debt$4.72B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$8.88B$338.2M$98.7M$376.9M
FY-1$8.87B$457.4M$108.0M$29.6M
FY-2$8.00B$455.2M$118.8M$143.6M
FY-3$8.95B$450.8M$129.7M-$67.4M
FY-4$8.25B$334.5M$90.8M$228.8M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$13.10B$3.32B$159.9M
FY-1$12.96B$3.47B$80.6M
FY-2$11.43B$3.28B$107.9M
FY-3$10.61B$3.10B$87.5M
FY-4$10.27B$3.06B$95.5M
PeriodOCFCapExFCFSBC
FY0$671.6M-$313.9M$376.9M
FY-1$625.5M-$664.9M$29.6M
FY-2$563.8M-$501.9M$143.6M
FY-3$988.5M-$767.8M-$67.4M
FY-4-$76.3M-$384.9M$228.8M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$2.45B$109.0M$78.3M$186.3M
FQ-1$2.14B$67.4M-$7.2M$93.2M
FQ-2$1.98B$65.5M$8.9M$128.0M
FQ-3$2.30B$96.3M$18.6M$94.9M
FQ-4$2.25B$118.6M$60.0M$46.9M
FQ-5$2.27B$100.7M$7.7M$102.2M
FQ-6$2.31B$132.7M$26.6M-$93.3M
FQ-7$2.05B$105.5M$13.7M$99.3M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$13.10B$3.32B$159.9M
FQ-1$13.00B$3.35B$150.3M
FQ-2$12.58B$3.25B$134.4M
FQ-3$12.81B$3.47B$148.5M
FQ-4$12.96B$3.47B$80.6M
FQ-5$12.74B$3.47B$104.4M
FQ-6$12.82B$3.46B$83.7M
FQ-7$12.11B$3.34B$124.8M
PeriodOCFCapExFCFSBC
FQ0$671.6M-$313.9M$186.3M
FQ-1$218.2M-$239.3M$93.2M
FQ-2$327.9M-$162.2M$128.0M
FQ-3$107.6M-$99.6M$94.9M
FQ-4$625.5M-$664.9M$46.9M
FQ-5$263.6M-$469.0M$102.2M
FQ-6$132.2M-$398.6M-$93.3M
FQ-7$12.2M-$90.6M$99.3M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$3.32B
Net cash-$4.56B
Current ratio1.3
Debt/Equity1.4
ROA0.8%
ROE3.0%
Cash conversion6.8%
CapEx/Revenue-3.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Apparel & Accessories · cohort 2 companies
Metric2906Activity
Op margin3.8%6.6% medp25 4.6% · p75 8.7%bottom quartile
Net margin1.1%3.7% medp25 2.0% · p75 5.5%bottom quartile
Gross margin29.5%57.5% medp25 57.5% · p75 57.5%bottom quartile
CapEx / revenue-3.5%1.1% medp25 0.9% · p75 1.4%bottom quartile
Debt / equity142.0%124.3% medp25 86.1% · p75 162.6%above median
Recent coverage
Observations
IR observations
Last actual EPS0.19 TWD
Last actual revenue8,423,971,000 TWD
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 08:31 UTC#c1b4e1b0
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 08:34 UTCJob: 5fb9a0ee